Rethinking mycoplasma testing: 1-hour results in cell and gene therapy QC case study

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Rethinking mycoplasma testing: 1-hour results in cell and gene therapy QC case study

Mycoplasma testing remains one of the most time-consuming steps in cell and gene therapy (CGT) QC, with long turnaround times and workflow complexity slowing lot release decisions. This webinar examines how a rapid mycoplasma testing solution can be implemented in pharmaceutical QC environments to deliver results in around an hour, with minimal hands-on complexity.

Drawing on a real-world case study, the speakers will share testing strategies, adoption considerations, and lessons learned from routine use. The discussion will also cover day-to-day laboratory workflow, ease of use, and reporting practices that support timely, confident quality decisions.

Attend this webinar to:

Hear a real-world case study on adopting rapid mycoplasma testing in a pharmaceutical QC environment, including implementation strategies and lessons learned from routine use
Understand how a 1-hour testing workflow can shorten release timelines and simplify QC operations for CGT manufacturers
Gain insight into the day-to-day user experience, including workflow fit, ease of use, and operational efficiency in the QC laboratory
Learn how rapid mycoplasma testing supports reporting practices and quality decision-making while maintaining confidence in results

Jeremy Robertson

Global Solutions Manager at bioMérieux

Jeremy Robertson is a global life sciences business leader with more than 20 years of experience spanning biotechnology, rapid microbiological methods, product management, technical support, commercial strategy, and global marketing. This diverse background has given him a unique perspective on the intersection of science, technology, and business strategy. He currently serves as Global Solutions Manager for BIOFIRE® at bioMérieux, where he leads global initiatives focused on advancing rapid microbiological quality control solutions for the pharmaceutical and biotechnology industries. A graduate of the University of South Florida, Jeremy is passionate about helping pharmaceutical manufacturers adopt innovative technologies that improve product quality, accelerate release timelines, and strengthen patient safety.

In 47 Days

You have registered for this webinar